<?xml version="1.0" encoding="UTF-8"?>
<document id="30166519">
	<sentence id="s1" text="This is prototypically exemplified by neuroblastoma, where MYCN amplification occurs in about 25% of the cases.">
		<entity id="s1.e1" charOffset="38-51"
			type="HP" text="neuroblastoma" ontology_id="HP_0003006"/>
		<entity id="s1.e2" charOffset="59-63"
			type="GENE" text="MYCN" ontology_id="4613"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Encapsulation of mirin in nanoparticles allowed its use on MYCN-amplified neuroblastoma xenografts in vivo, which resulted in a sharp impairment of tumor growth, associated with DDR activation, p53 accumulation, and cell death.">
		<entity id="s2.e1" charOffset="74-87"
			type="HP" text="neuroblastoma" ontology_id="HP_0003006"/>
		<entity id="s2.e2" charOffset="148-153"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="194-197"
			type="GENE" text="p53" ontology_id="7157"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="true"/>
	</sentence>
</document>
